⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Investors Urged to Contact Levi & Korsinsky for Information Before October 5, 2026 - ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
Pomerantz LLP Advises Shareholders of Class Action Involving ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Did You Lose Money on ARS Pharmaceuticals, Inc. (SPRY)? Levi & Korsinsky Urges Investors to Act Before October 5, 2026
accessnewswire.com
SPRY
SPRY UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
October 5, 2026 Deadline: Join Class Action Lawsuit Against ARS Pharmaceuticals, Inc. (SPRY) – Contact Levi & Korsinsky
accessnewswire.com
SPRY
SPRY DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds ARS Pharmaceuticals Inc. Investors to Join the Class Action Lawsuit Today
accessnewswire.com
SPRY
Investors Urged to Contact Levi & Korsinsky for Information Before October 5, 2026 – ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
Pomerantz LLP Advises Shareholders of Class Action Involving ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPRY
globenewswire.com
SPRY
October 5, 2026 Deadline Approaching: Join Class Action Against ARS Pharmaceuticals, Inc. (SPRY) – Contact Levi & Korsinsky
accessnewswire.com
SPRY